ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $12,000 | +50.0% | 3,100 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | -11.1% | 3,100 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | +50.0% | 3,100 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | -72.7% | 3,100 | 0.0% | 0.00% | – |
| Q4 2019 | $22,000 | -21.4% | 3,100 | -50.0% | 0.00% | – |
| Q3 2019 | $28,000 | -6.7% | 6,200 | +100.0% | 0.00% | – |
| Q2 2019 | $30,000 | -58.9% | 3,100 | -50.8% | 0.00% | – |
| Q1 2019 | $73,000 | -2.7% | 6,300 | 0.0% | 0.00% | – |
| Q4 2018 | $75,000 | -29.9% | 6,300 | 0.0% | 0.00% | – |
| Q3 2018 | $107,000 | 0.0% | 6,300 | 0.0% | 0.00% | – |
| Q2 2018 | $107,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|